Silencing circ-MTHFD1L caused a decrease in BRCA1/2 expression or other unknown changes in BRCAness-associated proteins, undoubtedly pointing out a new direction for circ-MTHFD1L as a therapeutic target for pancreatic cancer. This evidence concerns the gene MTHFD1L and familial pancreatic carcinoma.